Elisabetta Lazzarini

Padova, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

PIK3CA mutations and first-line outcomes in endocrine-resistant HR+/HER2- metastatic breast cancer: A multicentric real-world study.

PIK3CA mutations and first-line outcomes in endocrine-resistant HR+/HER2- metastatic breast cancer: A multicentric real-world study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 09, 2025

Molecular immune signature identifies microglia and NK cell infiltration as a favorable prognostic marker in adult-type high-grade glioma.

Molecular immune signature identifies microglia and NK cell infiltration as a favorable prognostic marker in adult-type high-grade glioma.

Journal: ESMO open

Published: August 12, 2025

Baseline levels and dynamic changes of cfDNA, tumor fraction and mutations to anticipate the clinical course of small cell lung cancer (SCLC) patients treated with first-line atezolizumab and chemotherapy: an hypothesis generating study (CATS/ML43257).

Baseline levels and dynamic changes of cfDNA, tumor fraction and mutations to anticipate the clinical course of small cell lung cancer (SCLC) patients treated with first-line atezolizumab and chemotherapy: an hypothesis generating study (CATS/ML43257).

Journal: Journal of experimental & clinical cancer research : CR

Published: March 12, 2025

Somatic Copy Number Alterations in Circulating Cell-Free DNA as a Prognostic Biomarker for Hepatocellular Carcinoma: Insights from a Proof-of-Concept Study.

Somatic Copy Number Alterations in Circulating Cell-Free DNA as a Prognostic Biomarker for Hepatocellular Carcinoma: Insights from a Proof-of-Concept Study.

Journal: Cancers

Published: February 20, 2025

Unique Genetic and Epigenetic Alterations in Glioblastoma Long-Term Survivors: Insights From Two Clinical Cases.

Unique Genetic and Epigenetic Alterations in Glioblastoma Long-Term Survivors: Insights From Two Clinical Cases.

Journal: Journal of cellular and molecular medicine

Published: November 30, 2024

Pathogenic mitochondrial DNA variants are associated with response to anti-VEGF therapy in ovarian cancer PDX models.

Pathogenic mitochondrial DNA variants are associated with response to anti-VEGF therapy in ovarian cancer PDX models.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 24, 2024

Is There a Link between Chronic Obstructive Pulmonary Disease and Lung Adenocarcinoma? A Clinico-Pathological and Molecular Study.

Is There a Link between Chronic Obstructive Pulmonary Disease and Lung Adenocarcinoma? A Clinico-Pathological and Molecular Study.

Journal: Journal of personalized medicine

Published: June 24, 2024

Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: A multicentric retrospective study.

Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: A multicentric retrospective study.

Journal: Cancer letters

Published: October 24, 2023

Anti-VEGF therapy selects for clones resistant to glucose starvation in ovarian cancer xenografts.

Anti-VEGF therapy selects for clones resistant to glucose starvation in ovarian cancer xenografts.

Journal: Journal of experimental & clinical cancer research : CR

Published: April 20, 2023

Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors.

Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors.

Journal: Journal of neuro-oncology

Published: January 31, 2023

Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation.

Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 21, 2022

Distinct molecular signature of phospholamban p.Arg14del arrhythmogenic cardiomyopathy.

Distinct molecular signature of phospholamban p.Arg14del arrhythmogenic cardiomyopathy.

Journal: Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology

Published: September 21, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026